The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ethinyl Estradiol and Levonorgestrel Market Research Report 2025
Synopsis
This combination hormone medication is used to prevent pregnancy. It contains 2 hormones: levonorgestrel (a progestin) and ethinyl estradiol (an estrogen).
The global Ethinyl Estradiol and Levonorgestrel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ethinyl Estradiol and Levonorgestrel is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ethinyl Estradiol and Levonorgestrel is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ethinyl Estradiol and Levonorgestrel include Teva, Pfizer, Aurobindo Pharma, Laboratorios Leon Farma, Glenmark, Allergan, Avion Pharmaceuticals, LUPIN and Mayne Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ethinyl Estradiol and Levonorgestrel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ethinyl Estradiol and Levonorgestrel.
Report Scope
The Ethinyl Estradiol and Levonorgestrel market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ethinyl Estradiol and Levonorgestrel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ethinyl Estradiol and Levonorgestrel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Pfizer
Aurobindo Pharma
Laboratorios Leon Farma
Glenmark
Allergan
Avion Pharmaceuticals
LUPIN
Mayne Pharma
Novast
Mylan
Amneal Pharmaceuticals
Segment by Type
0.02mg/0.1mg
0.03mg/0.15mg
0.01mg/0.15mg
0.02mg/0.09mg
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ethinyl Estradiol and Levonorgestrel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ethinyl Estradiol and Levonorgestrel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This combination hormone medication is used to prevent pregnancy. It contains 2 hormones: levonorgestrel (a progestin) and ethinyl estradiol (an estrogen).
The global Ethinyl Estradiol and Levonorgestrel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ethinyl Estradiol and Levonorgestrel is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ethinyl Estradiol and Levonorgestrel is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ethinyl Estradiol and Levonorgestrel include Teva, Pfizer, Aurobindo Pharma, Laboratorios Leon Farma, Glenmark, Allergan, Avion Pharmaceuticals, LUPIN and Mayne Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ethinyl Estradiol and Levonorgestrel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ethinyl Estradiol and Levonorgestrel.
Report Scope
The Ethinyl Estradiol and Levonorgestrel market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ethinyl Estradiol and Levonorgestrel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ethinyl Estradiol and Levonorgestrel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Pfizer
Aurobindo Pharma
Laboratorios Leon Farma
Glenmark
Allergan
Avion Pharmaceuticals
LUPIN
Mayne Pharma
Novast
Mylan
Amneal Pharmaceuticals
Segment by Type
0.02mg/0.1mg
0.03mg/0.15mg
0.01mg/0.15mg
0.02mg/0.09mg
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ethinyl Estradiol and Levonorgestrel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ethinyl Estradiol and Levonorgestrel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ethinyl Estradiol and Levonorgestrel Market Overview
1.1 Product Overview and Scope of Ethinyl Estradiol and Levonorgestrel
1.2 Ethinyl Estradiol and Levonorgestrel Segment by Type
1.2.1 Global Ethinyl Estradiol and Levonorgestrel Market Value Comparison by Type (2024-2030)
1.2.2 0.02mg/0.1mg
1.2.3 0.03mg/0.15mg
1.2.4 0.01mg/0.15mg
1.2.5 0.02mg/0.09mg
1.3 Ethinyl Estradiol and Levonorgestrel Segment by Application
1.3.1 Global Ethinyl Estradiol and Levonorgestrel Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Ethinyl Estradiol and Levonorgestrel Market Size Estimates and Forecasts
1.4.1 Global Ethinyl Estradiol and Levonorgestrel Revenue 2019-2030
1.4.2 Global Ethinyl Estradiol and Levonorgestrel Sales 2019-2030
1.4.3 Global Ethinyl Estradiol and Levonorgestrel Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ethinyl Estradiol and Levonorgestrel Market Competition by Manufacturers
2.1 Global Ethinyl Estradiol and Levonorgestrel Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ethinyl Estradiol and Levonorgestrel Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ethinyl Estradiol and Levonorgestrel Average Price by Manufacturers (2019-2024)
2.4 Global Ethinyl Estradiol and Levonorgestrel Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ethinyl Estradiol and Levonorgestrel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ethinyl Estradiol and Levonorgestrel, Product Type & Application
2.7 Ethinyl Estradiol and Levonorgestrel Market Competitive Situation and Trends
2.7.1 Ethinyl Estradiol and Levonorgestrel Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ethinyl Estradiol and Levonorgestrel Players Market Share by Revenue
2.7.3 Global Ethinyl Estradiol and Levonorgestrel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ethinyl Estradiol and Levonorgestrel Retrospective Market Scenario by Region
3.1 Global Ethinyl Estradiol and Levonorgestrel Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ethinyl Estradiol and Levonorgestrel Global Ethinyl Estradiol and Levonorgestrel Sales by Region: 2019-2030
3.2.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Region: 2019-2024
3.2.2 Global Ethinyl Estradiol and Levonorgestrel Sales by Region: 2025-2030
3.3 Global Ethinyl Estradiol and Levonorgestrel Global Ethinyl Estradiol and Levonorgestrel Revenue by Region: 2019-2030
3.3.1 Global Ethinyl Estradiol and Levonorgestrel Revenue by Region: 2019-2024
3.3.2 Global Ethinyl Estradiol and Levonorgestrel Revenue by Region: 2025-2030
3.4 North America Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
3.4.1 North America Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ethinyl Estradiol and Levonorgestrel Sales by Country (2019-2030)
3.4.3 North America Ethinyl Estradiol and Levonorgestrel Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
3.5.1 Europe Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ethinyl Estradiol and Levonorgestrel Sales by Country (2019-2030)
3.5.3 Europe Ethinyl Estradiol and Levonorgestrel Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
3.6.1 Asia Pacific Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ethinyl Estradiol and Levonorgestrel Sales by Country (2019-2030)
3.6.3 Asia Pacific Ethinyl Estradiol and Levonorgestrel Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
3.7.1 Latin America Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ethinyl Estradiol and Levonorgestrel Sales by Country (2019-2030)
3.7.3 Latin America Ethinyl Estradiol and Levonorgestrel Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ethinyl Estradiol and Levonorgestrel Market Facts & Figures by Country
3.8.1 Middle East and Africa Ethinyl Estradiol and Levonorgestrel Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ethinyl Estradiol and Levonorgestrel Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ethinyl Estradiol and Levonorgestrel Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Type (2019-2030)
4.1.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Type (2019-2024)
4.1.2 Global Ethinyl Estradiol and Levonorgestrel Sales by Type (2025-2030)
4.1.3 Global Ethinyl Estradiol and Levonorgestrel Sales Market Share by Type (2019-2030)
4.2 Global Ethinyl Estradiol and Levonorgestrel Revenue by Type (2019-2030)
4.2.1 Global Ethinyl Estradiol and Levonorgestrel Revenue by Type (2019-2024)
4.2.2 Global Ethinyl Estradiol and Levonorgestrel Revenue by Type (2025-2030)
4.2.3 Global Ethinyl Estradiol and Levonorgestrel Revenue Market Share by Type (2019-2030)
4.3 Global Ethinyl Estradiol and Levonorgestrel Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Application (2019-2030)
5.1.1 Global Ethinyl Estradiol and Levonorgestrel Sales by Application (2019-2024)
5.1.2 Global Ethinyl Estradiol and Levonorgestrel Sales by Application (2025-2030)
5.1.3 Global Ethinyl Estradiol and Levonorgestrel Sales Market Share by Application (2019-2030)
5.2 Global Ethinyl Estradiol and Levonorgestrel Revenue by Application (2019-2030)
5.2.1 Global Ethinyl Estradiol and Levonorgestrel Revenue by Application (2019-2024)
5.2.2 Global Ethinyl Estradiol and Levonorgestrel Revenue by Application (2025-2030)
5.2.3 Global Ethinyl Estradiol and Levonorgestrel Revenue Market Share by Application (2019-2030)
5.3 Global Ethinyl Estradiol and Levonorgestrel Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aurobindo Pharma Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Laboratorios Leon Farma
6.4.1 Laboratorios Leon Farma Corporation Information
6.4.2 Laboratorios Leon Farma Description and Business Overview
6.4.3 Laboratorios Leon Farma Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Laboratorios Leon Farma Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.4.5 Laboratorios Leon Farma Recent Developments/Updates
6.5 Glenmark
6.5.1 Glenmark Corporation Information
6.5.2 Glenmark Description and Business Overview
6.5.3 Glenmark Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Glenmark Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.5.5 Glenmark Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Allergan Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 Avion Pharmaceuticals
6.6.1 Avion Pharmaceuticals Corporation Information
6.6.2 Avion Pharmaceuticals Description and Business Overview
6.6.3 Avion Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Avion Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.7.5 Avion Pharmaceuticals Recent Developments/Updates
6.8 LUPIN
6.8.1 LUPIN Corporation Information
6.8.2 LUPIN Description and Business Overview
6.8.3 LUPIN Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LUPIN Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.8.5 LUPIN Recent Developments/Updates
6.9 Mayne Pharma
6.9.1 Mayne Pharma Corporation Information
6.9.2 Mayne Pharma Description and Business Overview
6.9.3 Mayne Pharma Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mayne Pharma Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.9.5 Mayne Pharma Recent Developments/Updates
6.10 Novast
6.10.1 Novast Corporation Information
6.10.2 Novast Description and Business Overview
6.10.3 Novast Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novast Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.10.5 Novast Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Corporation Information
6.11.2 Mylan Ethinyl Estradiol and Levonorgestrel Description and Business Overview
6.11.3 Mylan Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mylan Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.11.5 Mylan Recent Developments/Updates
6.12 Amneal Pharmaceuticals
6.12.1 Amneal Pharmaceuticals Corporation Information
6.12.2 Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Description and Business Overview
6.12.3 Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Amneal Pharmaceuticals Ethinyl Estradiol and Levonorgestrel Product Portfolio
6.12.5 Amneal Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ethinyl Estradiol and Levonorgestrel Industry Chain Analysis
7.2 Ethinyl Estradiol and Levonorgestrel Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ethinyl Estradiol and Levonorgestrel Production Mode & Process
7.4 Ethinyl Estradiol and Levonorgestrel Sales and Marketing
7.4.1 Ethinyl Estradiol and Levonorgestrel Sales Channels
7.4.2 Ethinyl Estradiol and Levonorgestrel Distributors
7.5 Ethinyl Estradiol and Levonorgestrel Customers
8 Ethinyl Estradiol and Levonorgestrel Market Dynamics
8.1 Ethinyl Estradiol and Levonorgestrel Industry Trends
8.2 Ethinyl Estradiol and Levonorgestrel Market Drivers
8.3 Ethinyl Estradiol and Levonorgestrel Market Challenges
8.4 Ethinyl Estradiol and Levonorgestrel Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
